SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s ruling clouded the future of contraception.
Companies are scrambling to accelerate research timelines, pressing insurers to cover approved products, and forging ahead to develop and deliver everything from on-demand, hormone-free female contraception to male birth control.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
